Ask Warren

DongKoo Bio & Pharma

006620 · KOSDAQ · ₩006620 · 동구바이오제약

₩3,250▲ ₩120 (3.83%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩59B₩58B₩62B₩62B₩60B₩59B₩58B₩66B
Cost of sales₩26B₩23B₩26B₩26B₩24B₩23B₩23B₩25B
Gross profit₩33B₩35B₩36B₩36B₩37B₩36B₩35B₩41B
Operating income−₩6.5B₩1.8B₩2.8B₩2.2B₩1.9B₩2.3B−₩482M₩7B
Net income−₩5.6B−₩578M₩52B−₩13B₩12B−₩721M−₩1.6B₩1.3B
Net income to shareholders−₩6.1B−₩577M₩41B−₩1.6B₩11B−₩681M−₩8.2B₩3.6B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩319B₩340B₩336B₩269B₩259B₩254B₩244B₩238B
Current assets₩118B₩113B₩126B₩111B₩104B₩116B₩107B₩101B
Cash and equivalents₩18B₩23B₩22B₩11B₩5.6B₩23B₩25B₩24B
Total liabilities₩176B₩191B₩184B₩158B₩147B₩152B₩139B₩123B
Current liabilities₩131B₩147B₩137B₩120B₩112B₩119B₩115B₩103B
Borrowings₩121B₩127B₩128B₩106B₩95B₩95B₩85B₩74B
Total equity₩143B₩149B₩152B₩111B₩112B₩102B₩105B₩115B
Shareholders' equity₩142B₩148B₩152B₩111B₩112B₩102B₩105B₩114B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩4.5B₩10B₩5.1B₩1.2B−₩11B₩195M−₩874M₩9.6B
Capital spending₩5.2B₩1.7B₩11B₩3.6B−₩809M₩3.7B₩1.8B₩3.5B
Free cash flow−₩755M₩8.7B−₩6.1B−₩2.4B−₩12B−₩3.5B−₩2.7B₩6.2B
Dividends paid₩0₩3.2B−₩1₩0₩3.2B₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: DongKoo Bio & Pharma / 동구바이오제약 / 006620 / KRX:006620

Source: KRX statistical information